文献速递神经肿瘤

靶向转铁蛋白受体1的光学成像在小鼠模型中识别胶质瘤边界

Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models.
PubMed 文献 · J Neurooncol · 2020-05-13

本研究合成靶向转铁蛋白受体1(TfR1)的近红外荧光探针Cy5-CRT,在小鼠胶质母细胞瘤(GBM)模型中验证其识别肿瘤边界的可行性。结果显示Cy5-CRT特异性聚集于GBM组织,能以高对比度检测肿瘤负荷并引导荧光手术切除,且识别肿瘤边界比临床用荧光素钠更清晰。

要点

  • Cy5-CRT靶向TfR1,可穿越血脑屏障并在GBM组织高聚集。
  • Cy5-CRT在正位GBM小鼠中实现荧光引导的肿瘤切除。
  • Cy5-CRT识别GBM边界比荧光素钠更清晰。

核心结论

  • 靶向TfR1的光学探针Cy5-CRT能以高灵敏度区分肿瘤组织与周围正常脑组织,有望用于GBM精准手术切除。

研究设计与样本

  • 临床前小鼠研究:在皮下和正位GBM模型中验证TfR1过表达及Cy5-CRT的肿瘤归巢能力,并在正位GBM异种移植中评估其识别肿瘤边界的可行性,最后与临床用荧光素钠对比识别肿瘤边界。

主要发现

  • Cy5-CRT特异性聚集于GBM组织,在正位GBM小鼠中以优异对比度检测肿瘤负荷。
  • Cy5-CRT支持近红外荧光活体成像条件下的荧光引导GBM切除。
  • Cy5-CRT识别GBM组织边界比荧光素钠更清晰。

临床怎么用

  • 提示TfR1靶向近红外荧光探针可能作为GBM术中荧光引导切除的候选工具,尚需进一步临床转化验证。

局限性

  • 研究仅在小鼠模型中进行,尚未在人体验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Optical molecular imaging technology that indiscriminately detects intracranial glioblastoma (GBM) can help neurosurgeons effectively remove tumor masses. Transferrin receptor 1 (TfR 1) is a diagnostic and therapeutic target in GBM. A TfR 1-targeted peptide, CRTIGPSVC (CRT), was shown to cross the blood brain barrier (BBB) and accumulate at high levels in GBM tissues. In this study, we synthesized a TfR 1-targeted near-infrared fluorescent (NIRF) probe, Cy5-CRT, for identifying the GBM tissue margin in mouse models. METHODS: We initially confirmed the overexpression of TfR 1 in GBM and the tumor-specific homing ability of Cy5-CRT in subcutaneous and orthotopic GBM mouse models. We then examined the feasibility of Cy5-CRT for identifying the tumor margin in orthotopic GBM xenografts. Finally, we compared Cy5-CRT with the clinically used fluorescein sodium in identifying tumor margins. RESULTS: Cy5-CRT specifically accumulated in GBM tissues and detected the tumor burden with exceptional contrast in mice with orthotopic GBM, enabling fluorescence-guided GBM resection under NIRF live imaging conditions. Importantly, Cy5-CRT recognized the GBM tissue margin more clearly than fluorescein sodium. CONCLUSIONS: The TfR 1-targeted optical probe Cy5-CRT specifically differentiates tumor tissues from the surrounding normal brain with high sensitivity, indicating its potential application for the precise surgical removal of GBM.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Ni XR, Zhao YY, Cai HP, et al. Transferrin receptor 1 targeted optical imaging for identifying glioma margin in mouse models. J Neurooncol. 2020. PMID: 32405996. doi:10.1007/s11060-020-03527-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。